Geneos Wealth Management Inc. Has $188,000 Holdings in RELX PLC $RELX

Geneos Wealth Management Inc. boosted its holdings in shares of RELX PLC (NYSE:RELX) by 52.0% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,732 shares of the technology company’s stock after acquiring an additional 1,277 shares during the quarter. Geneos Wealth Management Inc.’s holdings in RELX were worth $188,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of RELX. GAMMA Investing LLC boosted its position in RELX by 6,125.5% during the 1st quarter. GAMMA Investing LLC now owns 679,073 shares of the technology company’s stock worth $34,232,000 after acquiring an additional 668,165 shares during the period. Carnegie Investment Counsel acquired a new stake in RELX during the 1st quarter worth about $16,026,000. Ameriprise Financial Inc. boosted its position in RELX by 8.3% during the 1st quarter. Ameriprise Financial Inc. now owns 3,041,132 shares of the technology company’s stock worth $154,129,000 after acquiring an additional 234,094 shares during the period. Connor Clark & Lunn Investment Management Ltd. boosted its position in RELX by 103.4% during the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 444,360 shares of the technology company’s stock worth $22,400,000 after acquiring an additional 225,947 shares during the period. Finally, Northern Trust Corp lifted its holdings in shares of RELX by 9.2% during the 1st quarter. Northern Trust Corp now owns 2,394,097 shares of the technology company’s stock valued at $120,686,000 after buying an additional 202,509 shares during the last quarter. 15.02% of the stock is currently owned by institutional investors and hedge funds.

RELX Stock Down 0.4%

Shares of RELX stock opened at $46.68 on Wednesday. The stock’s 50 day simple moving average is $49.53 and its 200 day simple moving average is $51.09. The company has a debt-to-equity ratio of 2.55, a quick ratio of 0.42 and a current ratio of 0.47. RELX PLC has a twelve month low of $44.19 and a twelve month high of $56.33. The company has a market capitalization of $85.55 billion, a price-to-earnings ratio of 25.10, a PEG ratio of 3.06 and a beta of 0.87.

RELX Cuts Dividend

The business also recently disclosed a semi-annual dividend, which was paid on Tuesday, September 16th. Investors of record on Friday, August 8th were paid a $0.2634 dividend. This represents a dividend yield of 170.0%. The ex-dividend date of this dividend was Friday, August 8th. RELX’s dividend payout ratio (DPR) is presently 28.49%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. Morgan Stanley reiterated an “overweight” rating on shares of RELX in a report on Thursday, September 11th. Wall Street Zen lowered RELX from a “buy” rating to a “hold” rating in a report on Friday, September 5th. Four research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy”.

RELX Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.